KalVista Pharmaceuticals, Inc. (FRA:4XC1)
11.40
-0.30 (-2.56%)
At close: Dec 3, 2025
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of €713.88 million as of December 5, 2025. Its market cap has increased by 69.71% in one year.
Market Cap
713.88M
Enterprise Value
691.03M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
€11.40
Market Cap Chart
Since November 23, 2016, KalVista Pharmaceuticals's market cap has increased from 78.86M to 713.88M, an increase of 805.28%. That is a compound annual growth rate of 27.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 130.38B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.66B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |